Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Transcranial pulsed electromagnetic fields for treatment-resistant depression: A multicenter 8-week single-arm cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The impact of mental vulnerability on the relationship between cardiovascular disease and depression

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Birth dimensions, severe mental illness and risk of type 2 diabetes in a cohort of Danish men born in 1953

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Association between prior somatic disease and 5-year relapse risk among 11,856 incident patients with schizophrenia

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Effectiveness of cognitive remediation in the ultra-high risk state for psychosis

    Research output: Contribution to journalLetterResearchpeer-review

  3. The Duffy-null genotype and risk of infection

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Associations between facial affect recognition and neurocognition in subjects at ultra-high risk for psychosis: A case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • EU-GEI High Risk Study Group
View graph of relations

BACKGROUND: Gender differences in symptomatology in chronic schizophrenia and first episode psychosis patients have often been reported. However, little is known about gender differences in those at risk of psychotic disorders. This study investigated gender differences in symptomatology, drug use, comorbidity (i.e. substance use, affective and anxiety disorders) and global functioning in patients with an at-risk mental state (ARMS) for psychosis.

METHODS: The sample consisted of 336 ARMS patients (159 women) from the prodromal work package of the EUropean network of national schizophrenia networks studying Gene-Environment Interactions (EU-GEI; 11 centers). Clinical symptoms, drug use, comorbidity and functioning were assessed at first presentation to an early detection center using structured interviews.

RESULTS: In unadjusted analyses, men were found to have significantly higher rates of negative symptoms and current cannabis use while women showed higher rates of general psychopathology and more often displayed comorbid affective and anxiety disorders. No gender differences were found for global functioning. The results generally did not change when corrected for possible cofounders (e.g. cannabis use). However, most differences did not withstand correction for multiple testing.

CONCLUSIONS: Findings indicate that gender differences in symptomatology and comorbidity in ARMS are similar to those seen in overt psychosis and in healthy controls. However, observed differences are small and would only be reliably detected in studies with high statistical power. Moreover, such small effects would likely not be clinically meaningful.

Original languageEnglish
JournalEuropean psychiatry : the journal of the Association of European Psychiatrists
Volume59
Pages (from-to)52-59
Number of pages8
ISSN0924-9338
DOIs
Publication statusPublished - Jun 2019

    Research areas

  • Comorbidity, Functioning, Gender differences, Risk for psychosis, Sex differences

ID: 58228288